Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03273686|
Recruitment Status : Unknown
Verified August 2017 by Jiaqing Xiang, Fudan University.
Recruitment status was: Not yet recruiting
First Posted : September 6, 2017
Last Update Posted : September 6, 2017
|Condition or disease||Intervention/treatment||Phase|
|Esophageal Cancer||Procedure: Discharge the NG tube during the surgery||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy: a Randomized Clinical Trial|
|Estimated Study Start Date :||September 15, 2017|
|Estimated Primary Completion Date :||January 15, 2018|
|Estimated Study Completion Date :||April 15, 2018|
Experimental: group without NG tube after surgery
In this goup, patients will undergo preoperative gastrointestinal decompression and investigators will discharge the NG tube during the surgery.
Procedure: Discharge the NG tube during the surgery
Discharge the NG tube during the surgery.
No Intervention: group with NG tube after surgery
In this goup, patients will undergo preoperative gastrointestinal decompression and investigators will discharge the NG tube 6-7 days after the surgery.
- postoperative complication [ Time Frame: an expected average of 4 weeks ]the occurrence of major pulmonary complications and anastomotic leaks.
- the need for placing/ replacing the NG tube [ Time Frame: an expected average of 2 weeks ]the need for placing/ replacing the NG tube
- Length of postoperative stay [ Time Frame: an expected average of 2 weeks ]Length of postoperative stay
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03273686
|Contact: Jiaqing Xiang, MD||+86 firstname.lastname@example.org|
|Contact: Yiliang Zhang, MD||+86 email@example.com|
|Principal Investigator:||Jiaqing Xiang, MD||Professor of Department of Thoracic Surgery, Fudan University Shanghai Cancer Center|